Download: Brochure - hemaPEN (research use only) [PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research use only (RUO) and not for therapeutic or diagnostic use.
View full product details
Download: Brochure - hemaPEN (research use only) (Japanese) [PDF]
hemaPENは開発中でプロトタイプデバイスが研究、調査目的のみで供給可能です。このデバイスは医療または診断には使用できません。Class 1血液採取と補完デバイスとしてhemaPENの登録が2019年末に予定されています。
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Instructions for use - hemaPEN (research use only) [PDF]
Also see: Video - Instructional video for hemaPEN use (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Instructions for use - hemaPEN opening tool [PDF]
The opening tool can only be used in conjunction with Trajan’s hemaPEN. The hemaPEN opening tool has been designed to assist in the retrieval of the dried blood spot samples from internal body of hemaPEN.
View full product details
Download: Part Number List - hemaPEN (research use only) [PDF]
Also see: Product Data Sheet - hemaPEN (research use only)
Find in table:
| Part number | Part description and detail |
|---|---|
| 498100001 | hemaPEN D300S RUO |
| 498100011 | hemaPEN W300S RUO |
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Poster - Blood sampling made easy [PDF]
Author: Australian National Fabrication Facility (ANFF).
View full product details
Download: Product Data Sheet - hemaPEN (research use only) [PDF]
Also see: Part Number List - hemaPEN (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Product Specification Sheet - hemaPEN (research use only)[PDF]
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Download: Quick guide - hemaPEN (research use only) [PDF]
Also see: Instructions for use - hemaPEN use (research use only)
Also see: Video - Instructional video for hemaPEN use (research use only)
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490.
Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use. hemaPEN® is a registered trademark owned by Trajan Scientific Australia Pty Ltd.
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
Play the video below, or view on our YouTube channel.
Also see: Instructions for use - hemaPEN
hemaPEN® is supplied for therapeutic or IVD use in Australia, New Zealand, UK, EU and USA only: ARTG number: 280007; CE mark, general IVD; US FDA number: D410490. Outside of the territories listed above, the hemaPEN is supplied for research purposes only and not for therapeutic or diagnostic use.
View full product details
